Alterations of the sphingolipid pathway in Alzheimer's disease: New biomarkers and treatment targets?

NeuroMolecular Medicine

Volumn 12, Issue 4, 2010, Pages 331-340

  Mielke, Michelle M ^a   Lyketsos, Constantine G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer; Biomarker; Ceramide; CSF; Humans; Plasma; Sphingolipid; Sphingomyelin; Sulfatide

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CERAMIDE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SULFATIDE;

ALZHEIMER DISEASE; AUTOPSY; CEREBROSPINAL FLUID LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; HUMAN; LIPID BLOOD LEVEL; LIPID BRAIN LEVEL; LIPID METABOLISM; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL MARKERS; BRAIN; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; SPHINGOLIPIDS; TAU PROTEINS;

ANIMALIA;

EID: 78649780371     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-010-8121-y     Document Type: Review

References (60)

1. T Ariga MP McDonald RK Yu 2008 Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease-a review Journal of Lipid Research 49 1157 1175 1:CAS:528:DC%2BD1cXmslWntL4%3D 10.1194/jlr.R800007-JLR200 18334715
2. VV Bandaru J Troncoso D Wheeler O Pletnikova J Wang K Conant NJ Haughey 2009 ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain Neurobiology of Aging 30 591 599 1:CAS:528:DC%2BD1MXjtF2nsL4%3D 10.1016/j.neurobiolaging.2007.07.024 17888544
3. L Berg DW McKeel Jr JP Miller M Storandt EH Rubin JC Morris, et al. 1998 Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype Archives of Neurology 55 326 335 1:STN:280: DyaK1c7nvVyhug%3D%3D 10.1001/archneur.55.3.326 9520006 (Pubitemid 28146197)
4. EH Corder AM Saunders WJ Strittmatter DE Schmechel PC Gaskell GW Small, et al. 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 921 923 1:CAS:528:DyaK3sXmtVWjur8%3D 10.1126/science.8346443 8346443
5. RG Cutler J Kelly K Storie WA Pedersen A Tammara K Hatanpaa, et al. 2004 Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease PNAS 101 2070 2075 1:CAS:528:DC%2BD2cXhs1Srsrw%3D 10.1073/pnas.0305799101 14970312 (Pubitemid 38229016)
6. RG Cutler WA Pedersen S Camandola JD Rothstein MP Mattson 2002 Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis Annals of Neurology 52 448 457 1:CAS:528:DC%2BD38XotlOjtr4%3D 10.1002/ana.10312 12325074
7. RB DeMattos RP Brendza JE Heuser M Kierson JR Cirrito J Fryer, et al. 2001 Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice Neurochemistry International 39 415 425 1:CAS:528:DC%2BD3MXntVymu7s%3D 10.1016/S0197-0186(01)00049-3 11578777 (Pubitemid 32907406)
8. B Dubois HH Feldman C Jacova ST Dekosky P Barberger-Gateau J Cummings, et al. 2007 Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria Lancet Neurology 6 734 746 10.1016/S1474-4422(07) 70178-3 17616482 (Pubitemid 47058377)
9. CP Ferri M Prince C Brayne H Brodaty L Fratiglioni M Ganguli, et al. 2005 Global prevalence of dementia: A Delphi consensus study Lancet 366 2112 2117 10.1016/S0140-6736(05)67889-0 16360788 (Pubitemid 41797645)
10. HM Fillit 2000 The pharmacoeconomics of Alzheimer's disease The American Journal of Managed Care 6 S1139 S1144 1:STN:280:DC%2BD3M%2FpslCntA%3D%3D 11142178
11. V France-Lanord B Brugg PP Michel Y Agid M Ruberg 1997 Mitochondrial free radical signal in ceramide-dependent apoptosis: A putative mechanism for neuronal death in Parkinson's disease Journal of Neurochemistry 69 1612 1621 1:CAS:528:DyaK2sXmsVCksbs%3D 10.1046/j.1471-4159.1997.69041612.x 9326290 (Pubitemid 27406962)
12. R Frank R Hargreaves 2003 Clinical biomarkers in drug discovery and development Nature Reviews 2 566 580 1:CAS:528:DC%2BD3sXltVakt78%3D 10.1038/nrd1130 12838269 (Pubitemid 37361748)
13. MO Grimm HS Grimm AJ Patzold EG Zinser R Halonen M Duering, et al. 2005 Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin Nature Cell Biology 7 1118 1123 1:CAS:528:DC%2BD2MXht1WqtrjI 10.1038/ncb1313 16227967
14. JH Growdon DJ Selkoe A Roses, et al. 1998 Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group Neurobiology of Aging 19 109 116 10.1016/S0197-4580(98)00022-0 (Pubitemid 28167748)
15. E Gulbins R Kolesnick 2003 Raft ceramide in molecular medicine Oncogene 22 7070 7077 1:CAS:528:DC%2BD3sXotVWktb4%3D 10.1038/sj.onc.1207146 14557812 (Pubitemid 37386676)
16. X Han 2005 Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: Implication of the role of lipids in the pathogenesis of Alzheimer's disease Current Alzheimer Research 2 65 77 1:CAS:528:DC%2BD2MXhsFegtb8%3D 10.2174/1567205052772786 15977990 (Pubitemid 41389260)
17. X Han H Cheng JD Fryer AM Fagan DM Holtzman 2003 Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content The Journal of Biological Chemistry 278 8043 8051 1:CAS:528:DC%2BD3sXhsF2iurs%3D 10.1074/jbc.M212340200 12501252 (Pubitemid 36800543)
18. X Han AM Fagan H Cheng JC Morris C Xiong DM Holtzman 2003 Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia Annals of Neurology 54 115 119 1:CAS:528:DC%2BD3sXlvVWisrg%3D 10.1002/ana.10618 12838527 (Pubitemid 36764988)
19. X Han D Holtzman DW McKeel Jr J Kelley JC Morris 2002 Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: Potential role in disease pathogenesis Journal of Neurochemistry 82 809 818 1:CAS:528:DC%2BD38XmsF2htbY%3D 10.1046/j.1471-4159.2002.00997.x 12358786
20. NJ Haughey RG Cutler A Tamara JC McArthur DL Vargas CA Pardo, et al. 2004 Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia Annals of Neurology 55 257 267 1:CAS:528:DC%2BD2cXhs1Sgur8%3D 10.1002/ana.10828 14755730 (Pubitemid 38167003)
21. X He Y Huang B Li CX Gong EH Schuchman 2010 Deregulation of sphingolipid metabolism in Alzheimer's disease Neurobiology of Aging 31 3 398 408 1:CAS:528:DC%2BC3cXntVWruw%3D%3D 10.1016/j.neurobiolaging.2008.05.010 18547682
22. LE Hebert PA Scherr JL Bienias DA Bennett DA Evans 2003 Alzheimer disease in the US population: Prevalence estimates using the 2000 census Archives of Neurology 60 1119 1122 10.1001/archneur.60.8.1119 12925369 (Pubitemid 36975801)
23. A Hofman A Ott MM Breteler ML Bots AJ Slooter F van Harskamp, et al. 1997 Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study Lancet 349 151 154 1:STN:280:DyaK2s3msFKgsw%3D%3D 10.1016/S0140-6736(96)09328-2 9111537 (Pubitemid 27039193)
24. WL Holland SA Summers 2008 Sphingolipids, insulin resistance, and metabolic disease: New insights from in vivo manipulation of sphingolipid metabolism Endocrine Reviews 29 381 402 1:CAS:528:DC%2BD1cXosVCqu7w%3D 10.1210/er.2007-0025 18451260 (Pubitemid 351831506)
25. C Holmes D Boche D Wilkinson G Yadegarfar V Hopkins A Bayer, et al. 2008 Long-term effects of Abeta42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebo-controlled phase I trial Lancet 372 216 223 1:CAS:528:DC%2BD1cXoslWkt74%3D 10.1016/S0140-6736(08)61075-2 18640458 (Pubitemid 351978111)
26. Y Huang H Tanimukai F Liu K Iqbal I Grundke-Iqbal CX Gong 2004 Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain European Journal of Neuroscience 20 3489 3497 10.1111/j.1460-9568.2004.03852.x 15610181 (Pubitemid 40013558)
27. CP Hughes L Berg WL Danziger LA Coben RL Martin 1982 A new clinical scale for the staging of dementia British Journal of Psychiatry 140 266 572 10.1192/bjp.140.6.566 (Pubitemid 12124384)
28. JY Hur H Welander H Behbahani M Aoki J Franberg B Winblad, et al. 2008 Active gamma-secretase is localized to detergent-resistant membranes in human brain FEBS Journal 275 1174 1187 1:CAS:528:DC%2BD1cXjslCisbs%3D 10.1111/j.1742-4658.2008.06278.x 18266764 (Pubitemid 351342213)
29. I Ichi K Nakahara Y Miyashita A Hidaka S Kutsukake K Inoue, et al. 2006 Association of ceramides in human plasma with risk factors of atherosclerosis Lipids 41 859 863 1:CAS:528:DC%2BD28Xht1yjtLrM 10.1007/s11745-006-5041-6 17152923 (Pubitemid 44788907)
30. A Jana K Pahan 2004 Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease Journal of Biological Chemistry 279 51451 51459 1:CAS:528:DC%2BD2cXhtVaqs73M 10.1074/jbc.M404635200 15452132 (Pubitemid 40017893)
31. AF Jorm D Jolley 1998 The incidence of dementia: A meta-analysis Neurology 51 728 733 1:STN:280:DyaK1cvhvVyisQ%3D%3D 9748017 (Pubitemid 28449250)
32. L Kalvodova N Kahya P Schwille R Ehehalt P Verkade D Drechsel K Simons 2005 Lipids as modulators of proteolytic activity of BACE: Involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro The Journal of Biological Chemistry 280 36815 36823 1:CAS:528:DC%2BD2MXhtFKhtL%2FK 10.1074/jbc.M504484200 16115865 (Pubitemid 41587762)
33. P Katsel C Li V Haroutunian 2007 Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochemical Research 32 845 856 1:CAS:528:DC%2BD2sXjtlymtL4%3D 10.1007/s11064-007-9297-x 17342407 (Pubitemid 46481322)
34. S Koch N Donarski K Goetze M Kreckel HJ Stuerenburg C Buhmann U Beisiegel 2001 Characterization of four lipoprotein classes in human cerebrospinal fluid Journal of Lipid Research 42 1143 1151 1:CAS:528:DC%2BD3MXlt1Kqs7o%3D 11441143 (Pubitemid 32645797)
35. JT Lee J Xu JM Lee G Ku X Han DI Yang, et al. 2004 Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase- ceramide pathway Journal of Cell Biology 164 123 131 1:CAS:528: DC%2BD2cXjs1Cksw%3D%3D 10.1083/jcb.200307017 14709545 (Pubitemid 38082463)
36. L Lomnitski L Oron D Sklan DM Michaelson 1999 Distinct alterations in phospholipid metabolism in brains of apolipoprotein E-deficient mice Journal of Neuroscience Research 58 586 592 1:CAS:528:DyaK1MXntlOhtLs%3D 10.1002/(SICI)1097-4547(19991115)58:4<586::AID-JNR11>3.0.CO;2-7 10533050 (Pubitemid 29530441)
37. CG Lyketsos CA Szekely MM Mielke PB Rosenberg PP Zandi 2008 Developing new treatments for Alzheimer's disease: The who, what, when, and how of biomarker-guided therapies International psychogeriatrics/IPA 20 871 889 18498669
38. RW Mahley 1988 Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology Science 240 622 630 1:CAS:528:DyaL1cXitFOrtr8%3D 10.1126/science.3283935 3283935
39. A Marinier A Martel J Banville C Bachand R Remillard P Lapointe, et al. 1997 Sulfated galactocerebrosides as potential antiinflammatory agents Journal of Medicinal Chemistry 40 3234 3247 1:CAS:528:DyaK2sXmtVehsL8%3D 10.1021/jm9606960 9379443 (Pubitemid 27413748)
40. MP Mattson RG Cutler DG Jo 2005 Alzheimer peptides perturb lipid-regulating enzymes Nature Cell Biology 7 1045 1047 1:CAS:528: DC%2BD2MXht1WqtrvM 10.1038/ncb1105-1045 16385731
41. N Mattsson H Zetterberg O Hansson N Andreasen L Parnetti M Jonsson, et al. 2009 CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment JAMA 302 385 393 1:CAS:528:DC%2BD1MXptVCgu7Y%3D 10.1001/jama.2009.1064 19622817 (Pubitemid 43202329)
42. R Mayeux 2003 Epidemiology of neurodegeneration Annual Review of Neuroscience 26 81 104 1:CAS:528:DC%2BD3sXntFSis7k%3D 10.1146/annurev.neuro.26. 043002.094919 12574495 (Pubitemid 37064929)
43. A Merched H Blain S Visvikis B Herbeth C Jeandel G Siest 1997 Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease Journal of the Neurological Sciences 145 33 39 1:CAS:528:DyaK2sXitVyqsrk%3D 10.1016/S0022-510X(96)00234-1 9073026 (Pubitemid 27141576)
44. MM Mielke VV Bandaru NJ Haughey PV Rabins CG Lyketsos MC Carlson 2010 Serum sphingomyelins and ceramides are early predictors of memory impairment Neurobiology of Aging 31 17 24 1:CAS:528:DC%2BD1MXhsValtbzP 10.1016/j. neurobiolaging.2008.03.011 18455839
45. Mielke, M. M., Bandaru, V. V. R., Haughey, N. J., Schech, S., Chu, M., Albert, M., et al. (2010b). Plasma ceramides are altered early in the course of Alzheimers disease. Alzheimer's & Dementia, in press.
46. MM Mielke CG Lyketsos 2006 Lipids and the pathogenesis of Alzheimer's disease: Is there a link? International Review of Psychiatry 18 173 186 10.1080/09540260600583007 16777671 (Pubitemid 43791680)
47. MM Mielke PB Rosenberg J Tschanz L Cook C Corcoran KM Hayden, et al. 2007 Vascular factors predict rate of progression in Alzheimer disease Neurology 69 1850 1858 1:STN:280:DC%2BD2snlvF2jtg%3D%3D 10.1212/01.wnl.0000279520.59792.fe 17984453 (Pubitemid 350071146)
48. BP Nathan S Bellosta DA Sanan KH Weisgraber RW Mahley RE Pitas 1994 Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro Science 264 850 852 1:CAS:528:DyaK2cXjt1SltLs%3D 10.1126/science.8171342 8171342 (Pubitemid 24193454)
49. JC Nelson XC Jiang I Tabas A Tall S Shea 2006 Plasma sphingomyelin and subclinical atherosclerosis: Findings from the multi-ethnic study of atherosclerosis American Journal of Epidemiology 163 903 912 10.1093/aje/kwj140 16611667 (Pubitemid 43752356)
50. A Ott RP Stolk F van Harskamp HA Pols A Hofman MM Breteler 1999 Diabetes mellitus and the risk of dementia: The Rotterdam Study Neurology 53 1937 1942 1:STN:280:DC%2BD3c%2Fms1Ontg%3D%3D 10599761 (Pubitemid 29100779)
51. JW Pettegrew K Panchalingam RL Hamilton RJ McClure 2001 Brain membrane phospholipid alterations in Alzheimer's disease Neurochemical Research 26 771 782 1:CAS:528:DC%2BD3MXmvFGhur8%3D 10.1023/A:1011603916962 11565608 (Pubitemid 32845968)
52. RE Pitas JK Boyles SH Lee D Hui KH Weisgraber 1987 Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain The Journal of Biological Chemistry 262 14352 14360 1:CAS:528:DyaL2sXlvFGntb8%3D 3115992 (Pubitemid 17152101)
53. M Pitto F Raimondo C Zoia L Brighina C Ferrarese M Masserini 2005 Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients Neurobiology of Aging 26 833 838 1:CAS:528:DC%2BD2MXhsVyqtbg%3D 10.1016/j.neurobiolaging.2004.07.006 15718041 (Pubitemid 40249485)
54. L Puglielli BC Ellis AJ Saunders DM Kovacs 2003 Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis The Journal of Biological Chemistry 278 19777 19783 1:CAS:528:DC%2BD3sXktVaqtrc%3D 10.1074/jbc.M300466200 12649271 (Pubitemid 36799164)
55. H Satoi H Tomimoto R Ohtani T Kitano T Kondo M Watanabe, et al. 2005 Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis Neuroscience 130 657 666 1:CAS:528:DC%2BD2cXhtVKlsbnE 10.1016/j.neuroscience.2004.08.056 15590150 (Pubitemid 39601439)
56. DA Snowdon SJ Kemper JA Mortimer LH Greiner DR Wekstein WR Markesbery 1996 Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study JAMA 275 528 532 1:STN:280:DyaK287ptVCntg%3D%3D 10.1001/jama.275.7.528 8606473 (Pubitemid 26061427)
57. WJ Strittmatter AM Saunders D Schmechel M Pericak-Vance J Enghild GS Salvesen AD Roses 1993 Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease PNAS 90 1977 1981 1:CAS:528:DyaK3sXhs1Klsrs%3D 10.1073/pnas.90.5.1977 8446617 (Pubitemid 23069980)
58. KH Weisgraber RW Mahley 1996 Human apolipoprotein E: The Alzheimer's disease connection FASEB J 10 1485 1494 1:CAS:528:DyaK28XntFWkurg%3D 8940294 (Pubitemid 26384445)
59. WL Xu CX Qiu A Wahlin B Winblad L Fratiglioni 2004 Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study Neurology 63 1181 1186 1:STN:280:DC%2BD2crgvVWhuw%3D%3D 15477535 (Pubitemid 39350014)
60. K Yanagisawa 2007 Role of gangliosides in Alzheimer's disease Biochimica et Biophysica Acta 1768 1943 1951 1:CAS:528:DC%2BD2sXosF2gt7g%3D 10.1016/j.bbamem.2007.01.018 17321494 (Pubitemid 47125848)